Oligogenic combinations associated with breast cancer risk in women under 53 years of age. (Q53362274)

13 May 2018

title

Oligogenic combinations associated with breast cancer risk in women under 53 years of age. (English)

1 reference

13 May 2018

author name string

Christopher E Aston

1 reference

13 May 2018

David A Ralph

1 reference

13 May 2018

Dominique P Lalo

1 reference

13 May 2018

Sharmila Manjeshwar

1 reference

13 May 2018

Bobby A Gramling

1 reference

13 May 2018

Daniele C DeFreese

1 reference

13 May 2018

Amy D West

1 reference

13 May 2018

Dannielle E Branam

1 reference

13 May 2018

Linda F Thompson

1 reference

13 May 2018

Melissa A Craft

1 reference

13 May 2018

Debra S Mitchell

1 reference

13 May 2018

Craig D Shimasaki

1 reference

13 May 2018

John J Mulvihill

1 reference

13 May 2018

Eldon R Jupe

1 reference

13 May 2018

publication date

21 December 2004

1 reference

13 May 2018

published in

Human Genetics

1 reference

13 May 2018

volume

116

1 reference

13 May 2018

issue

1 reference

13 May 2018

page(s)

208-221

1 reference

13 May 2018

Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study

cites work

1 reference

12 December 2020

BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family history

1 reference

12 December 2020

American Cancer Society guidelines for breast cancer screening: update 2003.

1 reference

12 December 2020

An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer

1 reference

12 December 2020

Long-term recreational physical activity and breast cancer in the National Health and Nutrition Examination Survey I epidemiologic follow-up study

1 reference

12 December 2020

Frequency of breast cancer attributable to BRCA1 in a population-based series of American women

1 reference

12 December 2020

Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer.

1 reference

12 December 2020

Future possibilities in the prevention of breast cancer: role of genetic variation in breast cancer prevention

1 reference

12 December 2020

High breast cancer incidence rates among California teachers: results from the California Teachers Study (United States).

1 reference

12 December 2020

A comprehensive evaluation of family history and breast cancer risk. The Utah Population Database

1 reference

12 December 2020

Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk.

1 reference

12 December 2020

Alternate splicing produces a novel cyclin D1 transcript

1 reference

12 December 2020

Polymorphic catechol-O-methyltransferase gene and breast cancer risk

1 reference

12 December 2020

DNA adduct levels and DNA repair polymorphisms in traffic-exposed workers and a general population sample

1 reference

12 December 2020

Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland

1 reference

12 December 2020

Long-term effects of fenretinide, a retinoic acid derivative, on the insulin-like growth factor system in women with early breast cancer

1 reference

12 December 2020

GSTM1, GSTT1, and GSTP1 genotypes in relation to breast cancer risk and frequency of mutations in the p53 gene

1 reference

12 December 2020

Epistasis: what it means, what it doesn't mean, and statistical methods to detect it in humans

1 reference

12 December 2020

Tumor suppression by the prohibitin gene 3'untranslated region RNA in human breast cancer

1 reference

12 December 2020

Family history, age, and risk of breast cancer. Prospective data from the Nurses' Health Study

1 reference

12 December 2020

High constant incidence in twins and other relatives of women with breast cancer.

1 reference

12 December 2020

Increased risk of prostate cancer associated with AA genotype of cyclin D1 gene A870G polymorphism

1 reference

12 December 2020

Factors associated with age at natural menopause in a multiethnic sample of midlife women

1 reference

12 December 2020

p53 haplotype determination in breast cancer.

1 reference

12 December 2020

Genetic variant of luteinizing hormone and risk of breast cancer in older women.

1 reference

12 December 2020

The prevalence of a family history of cancer in general practice

1 reference

12 December 2020

Prospective study of factors influencing the onset of natural menopause

1 reference

12 December 2020

BRCA1 mutations in primary breast and ovarian carcinomas

1 reference

12 December 2020

The HER2 I655V polymorphism and breast cancer risk in Ashkenazim

1 reference

12 December 2020

COMT genotype, micronutrients in the folate metabolic pathway and breast cancer risk

1 reference

12 December 2020

Mammographic density and breast cancer in three ethnic groups

1 reference

12 December 2020

Alternatively spliced forms of cyclin D1 modulate entry into the cell cycle in an inverse manner.

1 reference

12 December 2020

Inherited p53 gene mutations in breast cancer

1 reference

12 December 2020

Low rate of TP53 germline mutations in breast cancer/sarcoma families not fulfilling classical criteria for Li-Fraumeni syndrome

1 reference

12 December 2020

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

1 reference

12 December 2020

Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations and single-strand breaks in DNA

1 reference

12 December 2020

Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure, well-done meat intake, and breast cancer risk.

1 reference

12 December 2020

Analysis of the vitamin D system in cervical carcinomas, breast cancer and ovarian cancer.

1 reference

12 December 2020

Enzymology of human cytosolic sulfotransferases

1 reference

12 December 2020

Prospective study of the determinants of age at menopause

1 reference

12 December 2020

Cytochrome P450c17alpha gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations.

1 reference

12 December 2020

Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes?

1 reference

12 December 2020

Identification of the breast cancer susceptibility gene BRCA2

1 reference

12 December 2020

Vitamin-D-receptor-gene polymorphisms and change in lumbar-spine bone mineral density

1 reference

12 December 2020

Mammographic abnormalities and the detection of carcinoma of the breast

1 reference

12 December 2020

The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer

1 reference

12 December 2020

Structure-activity relationships and thermal stability of human glutathione transferase P1-1 governed by the H-site residue 105

1 reference

12 December 2020

Improving the prediction of complex diseases by testing for multiple disease-susceptibility genes

1 reference

12 December 2020

Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility

1 reference

12 December 2020

Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study

1 reference

12 December 2020

A multigene test for the risk of sporadic breast carcinoma

1 reference

12 December 2020

Germ-line HER-2 variant and breast cancer risk by stage of disease

1 reference

12 December 2020

Phenol Sulfotransferase Pharmacogenetics in Humans: Association of CommonSULT1A1Alleles with TS PST Phenotype

1 reference

12 December 2020

Residential magnetic fields and the risk of breast cancer

1 reference

12 December 2020

Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibility

1 reference

12 December 2020

Association of a vitamin D receptor polymorphism with sporadic breast cancer development

1 reference

12 December 2020

A potential mechanism underlying the increased susceptibility of individuals with a polymorphism in NAD(P)H:quinone oxidoreductase 1 (NQO1) to benzene toxicity

1 reference

12 December 2020

Molecular and functional characteristics of erbB2 in normal and cancer breast cells

1 reference

12 December 2020

Single nucleotide polymorphism in prohibitin 3' untranslated region and breast-cancer susceptibility

1 reference

12 December 2020

The CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis

1 reference

12 December 2020

Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders.

1 reference

12 December 2020

Multiplexed single nucleotide polymorphism genotyping by oligonucleotide ligation and flow cytometry

1 reference

12 December 2020

Risk factors for breast cancer in a population with high incidence rates

1 reference

12 December 2020

Association of vitamin D receptor gene polymorphism with sporadic breast cancer in Taiwanese patients.

1 reference

12 December 2020

Building a multigenic model of breast cancer susceptibility: CYP17 and HSD17B1 are two important candidates.

1 reference

12 December 2020

Modification of breast cancer risk in young women by a polymorphic sequence in the egfr gene

1 reference

12 December 2020

Cyclin D1 polymorphism and increased risk of colorectal cancer at young age

1 reference

12 December 2020

Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk.

1 reference

12 December 2020

CYP17 promoter polymorphism and breast cancer in Australian women under age forty years

1 reference

12 December 2020

Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility

1 reference

12 December 2020

Polymorphisms in the DNA repair enzyme XPD are associated with increased levels of PAH-DNA adducts in a case-control study of breast cancer

1 reference

12 December 2020

Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H:quinone oxidoreductase 1.

1 reference

12 December 2020

Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer

1 reference

12 December 2020

Naturally occurring human glutathione S-transferase GSTP1-1 isoforms with isoleucine and valine in position 104 differ in enzymic properties.

1 reference

12 December 2020

XPD polymorphisms: effects on DNA repair proficiency

1 reference

12 December 2020

ApaI polymorphisms of the vitamin D receptor predict bone density of the lumbar spine and not racial difference in bone density in young men.

1 reference

12 December 2020

A systematic review of genetic polymorphisms and breast cancer risk.

1 reference

12 December 2020

Phenol sulfotransferases: hormonal regulation, polymorphism, and age of onset of breast cancer

1 reference

12 December 2020

Low NAD(P)H:quinone oxidoreductase 1 activity is associated with increased risk of acute leukemia in adults

1 reference

12 December 2020

Polygenic susceptibility to breast cancer and implications for prevention

1 reference

12 December 2020

Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution

1 reference

12 December 2020

Flow cytometric platform for high-throughput single nucleotide polymorphism analysis

1 reference

12 December 2020

Progesterone receptor gene polymorphism is associated with decreased risk for breast cancer by age 50

1 reference

12 December 2020

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

1 reference

12 December 2020

10.1007/S00439-004-1206-7

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018